lysis; Kt/V; residual renal function; urea distribution volume Background. Inadequate dialysis dose is closely related to mortality and morbidity of maintenance haemodialysis (MHD) patients. According to the DOQI guidelines a minimum prescribed dialysis dose of single-Introduction pool Kt/V (Kt/V sp )=1.3, equivalent to equilibrated double pool Kt/V (e-Kt/V dp )=1.1, is recommended. Quality control of dialysis treatment has received wide Knowledge of patient-related risk factors for inadattention since a correlation between delivered dose of equate delivery of haemodialysis would be helpful to haemodialysis and patient mortality and morbidity has select patient subgroups for intensive control of dialysis been established [1][2][3][4][5]. As a consequence, guidelines adequacy.
urea concentration and the interdialytic time-average serum male patients with urea distribution volumes >42.0 urea concentration.
litres or body-surface areas >2.0 m2 are at increased Renal weekly Kt/V (r-Kt/V week ) was calculated as follows:
risk to receive inadequate dose of dialysis once residual renal function, expressed as renal Kt/V (r-Kt/V week ), r-Kt/V week =Cl urea ×10 080/V urea falls below a critical level of 0.3 per week.
where 10 080 reflects the number of minutes per week and V urea is the post-dialytic urea distribution volume (ml ).
Subjects and methods
Post-dialytic V urea (ml ) was estimated according to the formulae by Watson et al. [13] .
Total weekly Kt/V (t-Kt/V week ) was calculated according
Study cohort
to Teschan [14] : A retrospective analysis of the quality of dialysis treatment t-Kt/V week =3×e-Kt/V dp +r-Kt/V week . was performed for the months January to July 1997. The study cohort of 62 patients was selected from a total of 73 MHD patients treated regularly at our institution. Only Statistics patients with intact arteriovenous fistulae were evaluated. Patients dialysed via single-lumen central venous catheters Data are expressed as mean±SD. Statistical differences (n=9) or showing obvious shunt dysfunction (n=1) were between groups were compared by Wilcoxon's test for excluded. In addition, one patient with undetermined residual unpaired observations. Linear regression analysis and renal function was excluded. Results on 32 males and 30 Fisher's two-tailed exact test were performed when approfemales all dialysed thrice weekly using double-needle tech-priate. Statistical significance was assumed for P∏0.05. nique are reported.
The underlying renal diseases were diabetic nephropathy (n=21), vascular nephropathy (n=6), chronic glomerulo-Results nephritis (n=8), pyelointerstitial disease (n=10), hereditary kidney disease (n=4), acute renal failure (n=2), renal carcin- ( Table 1) oma (n=2), or unknown causes (n=9). Dose of dialysis ( Kt/V ) was assessed monthly and residual renal function Quality of haemodialysis treatment was retrospectively semiannualy in all patients. Only biocompatible dialysers examined over a period of 7 months in 62 MHD with surface areas Á1.7 m2 and no cuprophane membranes patients. The delivered dose of dialysis was assessed were used. Dialysate flow rate was 500 ml/min without by equilibrated double pool Kt/V (e-Kt/V dp ) and exception in all patients throughout the observation period.
Overall adequacy of haemodialysis dose
adequacy of a single dialysis treatment was defined as Table 1 summarizes characteristics of the study population.
In case of an inadequate delivered dialysis dose it is centre e-Kt/V dp Á1.10, with 1.09 being considered inadequate. policy to optimize blood flow to a maximum of 300 ml/min During the observation period 119 of a total of 320 and/or to prolong dialysis time by 30-min steps after e-Kt/V dp measurements (37.2%) were judged inadobtaining consent by the patient.
equate and mean e-Kt/V dp <1.10 was found in 35.5% of all patients ( Table 1) . Since residual renal function Calculations ments per patient (minimum 3 (n=3), maximum 6 (n=28)). Quality of dialysis treatment Midweek equilibrated double-pool Kt/V (e-Kt/V dp ) was e-Kt/V dp developed to estimate equilibrated Kt/V dp from unequilib-
Prevalence of inadequacy
rated post-dialysis serum urea concentration.
Single e-Kt/V dp <1.10 119/320 (37.2%)
Residual renal urea clearance (Cl urea , ml/min): Patients
Mean e-Kt/V dp <1.10 22/62 (35.5%) with interdialytic diuresis>250 ml (i.e.>125 ml per day) (RRF ) may contribute significantly to total weekly urea elimination, the introduction of total weekly dialytic and renal Kt/V (t-Kt/V week ) allows better judgement of dialysis adequacy. Thus, t-Kt/V week was determined for each month and t-Kt/V week Á3.30 was defined as adequate weekly urea removal. Applying this criterion of adequacy, the percentage of inadequate delivered dialysis doses was reduced to 22.8% (73 of 320 measurements), demonstrating that native kidney urea clearance compensated for insufficient dialytic urea removal in 46 of 320 evaluated dialysis treatments. Mean t-Kt/V week was inadequate in 19.4% (12/62) of patients. The percentage of t-Kt/V week <3.30 was higher during the first 2 months of the study period compared to the last 2 months (25 vs 20% respectively). This is partly explained by an increase in mean effective dialysis time from 219±36 min in month 1 to 229±32 min in month 7.
Gender-specific differences in dialysis quality (Table 2, Figure 1)
Mean t-Kt/V week was significantly lower in men than in women (3.58±0.60 vs 4.12±0.69 respectively, P=0.001). Treatment efficacy according to gender is depicted in Figure 1 . Mean e-Kt/V dP <1.10 was (e-Kt/V dp ), and (B) mean combined renal and dialytic Kt/V These ratios were lower after correction for RRF (t-Kt/V week ) during a 7-month evaluation period. Threshold of ( Figure 1B ). In 11 of 32 male patients (34%) mean adequacy (solid line) is defined as e-Kt/V dp patient received inadequate treatment. Thus, RRF compensated for the lack of dialytic urea removal in 10 patients (5 males, 5 females). The striking gender- 
Quality of dialysis treatment
Mean e-Kt/V dp 1. This retrospective longitudinal survey of haemodialysis specific differences in quality of HD treatment were adequacy was conducted to assess the prevalence of observed in spite of significantly longer dialysis times inadequate dialysis therapy according to current DOQI in men. Dialyser blood flow was high in both groups guidelines and identify patients at risk of inadequate and there was no difference in predialysis serum urea HD treatment. The results show that the average concentrations, degree of RRF, or percentage of dialysis dose in MHD patients treated with doublepatients with RRF. Body-height and body-weight were needle dialysis thrice weekly was lower in men than in higher in men compared to women and consequently women and that 'big men' with urea distribution male body surface area (BSA) as well as urea distribu-volumes >42.0 litres or body-surface areas >2.0 m2 tion volume ( UDV ) exceeded that of females.
are at increased risk of inadequate treatment. It is important to note that in 'big men' the achievement of adequacy significantly depended on the presence of
Characterization of inadequately treated male
residual renal function.
patients (Table 3, Figure 2)
There are various ways to assess the delivered dose of haemodialysis. Besides computer-based formal urea kinetic modelling [15] , simpler but equally appropriate A closer comparison of inadequately versus adequately treated males is given in Table 3 . Body-weight, BSA, formulae have been developed and validated [10] [11] [12] 16 ] . According to the recently published and UDV were significantly higher in inadequately dialysed men, whereas time since dialysis initiation and NKF-DOQI clinical practice guidelines for haemodialysis adequacy [6 ] a minimum delivered dialysis dose age were not different from adequately treated males. Dialysis regimen was similar in adequately and inad-of single pool Kt/V (Kt/V sp )=1.2 and a minimum prescribed dose of Kt/V sp =1.3 have been recomequately dialysed men, but r-Kt/V week was significantly lower in inadequately dialysed men.
mended. Although double-pool effects of urea removal can reduce the accuracy of single-pool urea kinetic Urea distribution volume ( Figure 2 ) and r-Kt/V week proved to be independent significant predictors of calculations, the use of single-pool, variable volume urea models has been given preference to assessment t-Kt/V week within a multiple linear regression model (P=0.001 and P=0.006 respectively). Addition of of double-pool Kt/V (e-Kt/V dp ) by the DOQI-HDAdequacy Work Group. The major argument in BMI, height, age, months since initiation of HD, and diabetes did not significantly improve prediction. favour of single-pool Kt/V assessment was that in nearly all relevant studies a relationship between doses Result were similar when UDV was replaced by BSA during analysis. In patients with UDV>42.0 litres the of haemodialysis estimated by single-pool, variable volume models and patient survival was shown. In risk of inadequate dialysis dose was significantly increased (odds ratio 5.10, 95% confidence interval general, e-Kt/V dp values are 0.10-0.3 points lower than Kt/V sp values, since urea rebound occurring after 1.02-25.5).
The impact of r-Kt/V week on the achievment of termination of HD is taken into consideration [18] . Residual renal function may contribute significantly adequate dialysis efficacy is further described in Table 4 . Among male patients with UDV>42.0 litres to total weekly urea elimination and thus, calculation of t-Kt/V week allows for a more accurate estimation of ('big men'), inadequate dialysis treatment was not observed when r-Kt/V week exceeded 0.30 per week. In urea elimination over the week. The impact of RRF on total weekly Kt/V in peritoneal dialysis (PD) is only one of seven patients with UDV>42.0 litres and r-Kt/V week <0.30 adequate dialysis quality was extensively discussed in the section on peritoneal dialysis adequacy of the DOQI guidelines [17] , and the achieved. UDV of this patient was 42.19 litres and [14] , which was applied in this study, may underesti- and inadequately dialysed patients and further stress the importance of RRF in 'big men'. Male gender was an important risk factor for inadauthors also comment on total weekly Kt/V in MHD equate dialysis in our study. Similarly, male gender patients. They stress that in order to assess adequately has been shown in various studies to be an independent the contribution of RRF to total weekly Kt/V in MHD risk factor for mortality of haemodialysis patients patients, e-Kt/V dp should be used to measure the [20] [21] [22] [23] . In contrast, there are also data documenting delivered dose of dialysis.
an increased mortality risk for female MHD patients Based upon data from Held et al. [3] showing that [24, 25] or no gender-specific mortality risk [26 ] . the risk of mortality is minimized at e-Kt/V dp Á1.05 Inadequate dialysis quality itself is an established morthrice weekly, i.e. Á3.15 per week, adequacy in our tality risk factor [1] [2] [3] [4] [5] . Nevertheless, it is at present study was defined as e-Kt/V dp Á1.10 and t-Kt/V week unclear whether larger males have a higher mortality Á3.30. In our study cohort almost 50% of patients risk than smaller males, since there are no studies had measurable RRF. That RRF may contribute examining mortality rates in these subpopulations. It significantly to total urea elimination in MHD patients has been documented before [7, 27, 28] that average is demonstrated by the fact that in 10 of 22 patients delivered dose of dialysis tends to be higher in females mean t-Kt/V week was adequate, although a mean compared to males, and this has been related to a e-Kt/V dp <1.10 was documented ( Figure 1 ). It is higher urea distribution volume in men. It has also obviously difficult to compare an intermittent dialytic been stated that smaller patients receive higher Kt/V urea removal with a continuous native kidney urea and this was considered suggestive of a lack of individualization of dialysis prescription [29] . It was the intenelimination in MHD patients. The method of Teschan tion of this study to go one step beyond these alteration of the dialysis schedule from 3×5 h to 4×4 h per week. This procedure may be favourable in observations by further characterizing inadequately dialysed men and describing a risk profile for those 'big men', although it is more costly and more timeconsuming for the patient. Further barriers to adequate receiving inadequate dialysis therapy. Our results show that male MHD patients with UDV>42.0 litres or delivery of haemodialysis include patient noncompliance, low dialysis prescription, use of catheter BSA>2.0 m2 were inadequately dialysed unless a significant degree of RRF (r-Kt/V week Á0.3) was preserved. for vascular access, and clotting [31] . Within the 7-month study period the percentage of underdialysed It is not clear whether UDV is an appropriate denominator for size adjustment of dialysis dose. In patients patients declined from 25% during the first 2 months to 20% during the last 2 months. This was mainly due with adequate to normal native kidney function, BSA is used instead of UDV as a denominator. Our data to prolongation of dialysis time, since similar to many other European centres blood flow in our facility rarely indicate that both UDV and BSA independently can be used to discriminate patients at risk of inadequate exceeds 300 ml/min. Retrospectively, the major barrier to adequacy during the study period was time limitadialysis.
It has to be noted that these data are from one tion imposed by the patients. It is our conclusion that specific efforts are required outpatient centre and thus may not be representative for other centres. Nevertheless, with regard to average to deliver an adequate dose of dialysis to 'big men'. This can be achieved by prolonging dialysis time, dialysis time and other treatment modalities we assume that our centre is representative for many European increasing blood flow, or eventually altering dialysis frequency. Adequacy of delivered haemodialysis dose dialysis centres. The EDTA report from 1996 [30] documents that in only a very small percentage of should be monitored regularly with special attention focused on patients presenting with the described risk European patients did the prescribed dialysis time exceed 12 h per week. It was further shown that the factors for inadequate treatment efficacy. Dose of dialysis needs to be carefully adapted to gradual losses number of patients dialysed for less than 12 h per week increased between 1988 and 1992 and that 46% of 1824 in residual renal function in 'big men'. European dialysis centres were not using urea kinetics for HD prescription in 1994.
The strength of our study is the inclusion of residual References renal function into the quality assessment of dialysis insignificant. It is also assumed that renal function
